Virtual Practice
Recommend

Dr. Guido Davidzon

Nuclear Medicine
Stanford, CA
About
Insights
Network
Welcome!
About me
I specialize in
Nuclear Medicine
Healthcare Professional
I have been in practice
16 years
I speak
English
Spanish
I'm known for
Doctor
Votes
Member
Votes
Knowledgeable
16th
Locally
1
PET scan
1st
Nationally
56
Nuclear scans
1st
Nationally
37
Recommend me
My answers and insights have
Saved 1 life
Helped 152,418 people
Received 828 doctor agrees
Received 242 thanks
Here are kind words from others
Dr. Davidzon is an amazing doctor! #nationaldoctorsday2015 #virtualflower1
Dr. Davidzon is an amazing doctor! #nationaldoctorsday2015 #virtualflower1
Recommend me
I am located at
Stanford University
300 Pasteur Dr
Stanford , CA 94305 , United States
Office hours
Mon 8:00am - 5:00pm
Tue 8:00am - 5:00pm
Wed 8:00am - 5:00pm
Thu 8:00am - 5:00pm
Fri 8:00am - 5:00pm
Accepted Insurance Plans
Aetna
Aetna Life Insurance Company
Blue Cross of California
I was educated and trained at
Medical / Graduate School
Maimonides University Faculty of Medicine, Argentina
Fellowships
Biomedical Informatics Harvard-MGH
Academic Appointments
Loyola University Chicago
I'm affiliated with
Hospitals
LOYOLA UNIVERSITY MEDICAL CENTER
LOYOLA GOTTLIEB MEMORIAL HOSPITAL
I've won the following awards
Top Nuclear Medicine Specialist, National
Summer 2013
Best Essay Travel Grant Award 2012 Mid-Winter SNM/ACNM Annual Meeting January 2012 Stanford University Medical Center Research titled:
Young Investigator Award Symposium SNM, Nuclear Oncology Council June 2011 Stanford University Medical Center
I've published
Case 207: hodgkin lymphoma with paraneoplastic hypercalcemic pancreatitis.
Radiology, 272, 296-300 (2014)
E S Mittra, G Davidzon
NF-?B protein expression associates with (18)F-FDG PET tumor uptake in non-small cell lung cancer: a radiogenomics validation study to understand tumor metabolism.
Lung cancer (Amsterdam, Netherlands), 83, 189-96 (2014)
V S Nair, O Gevaert, G Davidzon, S K Plevritis, R West
Prognostic PET 18F-FDG uptake imaging features are associated with major oncogenomic alterations in patients with resected non-small cell lung cancer.
Cancer research, 72, 3725-34 (2012)
V S Nair, O Gevaert, G Davidzon, S Napel, E E Graves, C D Hoang, J B Shrager, A Quon, D L Rubin, S K Plevritis